Chronic kidney disease and the heart. Linked pathologies;Enfermedad renal crónica y corazón. Un continuo evolutivo

Revista Espanola de Cardiologia

Volumn 61, Issue SUPPL. 2, 2008, Pages 41-51

  Bardají, Alfredo ^a   Martínez Vea, Alberto ^a  

^a HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

Author keywords

Cardiovascular disease; Hypertrophy; Kidneys

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT;

ATHEROSCLEROSIS; BLOOD VESSEL CALCIFICATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; DIALYSIS; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERPARATHYROIDISM; HYPERTENSION; KIDNEY FUNCTION; MENOPAUSE; MORBIDITY; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SITTING; ARTICLE; CARDIOLOGY; CHRONIC DISEASE; DISEASE COURSE; HEART DISEASE; KIDNEY DISEASE; NEPHROLOGY; RISK FACTOR;

CARDIOLOGY; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; DISEASE PROGRESSION; HEART DISEASES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY DISEASES; NEPHROLOGY; RISK FACTORS;

EID: 54549124600     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1157/13114956     Document Type: Article

References (44)

1. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004;164:659-63.
2. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108:2154-69.
3. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
4. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461-70.
5. Coresh J, Stevens LA. Kidney function estimating equations: where do we stand? Curr Opin Nephrol Hypertens. 2006;15:276-84.
6. Teruel JL, Sabater J, Galeano C, Rivera M, Merino JL, Fernández Lucas M, et al. The Cockcroft-Gault equation is better than MDRD equation to estimate the glomerular filtration rate in patients with advanced chronic renal failure. Nefrologia. 2007;27:313-9.
7. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004;351:1285-95.
8. Informe de la Sociedad Española de Nefrología año 2005. Disponible en: http://www.senefro.org/modules.php?name=home
9. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32:S112-9.
10. Herzog CA, Ma JZ, Collins AJ. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med. 1998;339:799-805.
11. Zager PG, Nikolic J, Brown RH, Campbell MA, Hunt WC, Peterson D, et al. "U" curve association of blood pressure and mortality in hemodialysis patients. Kidney Int. 1998;54:561-9 [fe de errores en: Kidney Int. 1998;54:1417].
12. Longenecker JC, Coresh J, Powe NR, Levey AS, Fink NE, Martin A, et al. Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study. J Am Soc Nephrol. 2002;13:1918-27.
13. Sarnak MJ, Coronado BE, Greene T, Wang SR, Kusek JW, Beck GJ, et al. Cardiovascular disease risk factors in chronic renal insufficiency. Clin Nephrol. 2002;57:327-35.
14. Martinez-Vea A, Salvadó E, Bardají A, Gutierrez C, Ramos A, García C, et al. Silent cerebral white matter lesions and their relationship with vascular risk factors in middle-aged predialysis patients with CKD. Am J Kidney Dis. 2006;47:241-50.
15. Ohtake T, Kobayashi S, Moriya H, Negishi K, Okamoto K, Maesato K, et al. High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: an angiographic examination. J Am Soc Nephrol. 2005;16:1141-8.
16. Rostand SG, Kirk KA, Rutsky EA. Dialysis-associated ischemic heart disease: insights from coronary angiography. Kidney Int. 1984;25:653-9.
17. London GM, Marchais SJ, Guerin AP, Metivier F, Adda H. Arterial structure and function in end-stage renal disease. Nephrol Dial Transplant. 2002;17:1713-24.
18. Bardají A, Martinez-Vea A, Valero A, Gutierrez C, Garcia C, Ridao C, et al. Cardiac involvement in autosomal-dominant polycystic kidney disease: a hypertensive heart disease. Clin Nephrol. 2001;56:211-20.
19. Martinez-Vea A, Bardaji A, Gutierrez C, Garcia C, Peralta C, Marcas L, et al. Exercise blood pressure, cardiac structure, and diastolic function in young normotensive patients with polycystic kidney disease: a prehypertensive state. Am J Kidney Dis. 2004;44:216-23.
20. Zoccali C, Bode-Böger S, Mallamaci F, Benedetto F, Tripepi G, Malatino L, et al. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet. 2001;358:2113-7.
21. Jofré R, Rodriguez-Benitez P, López-Gómez JM, Pérez-Garcia R. Inflammatory syndrome in patients on hemodialysis. J Am Soc Nephrol. 2006;17:S274-80.
22. Schiffrin EL, Touyz RM. From bedside to bench to bedside: role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension. Am J Physiol Heart Circ Physiol. 2004;287:H435-46.
23. Johnson RC, Leopold JA, Loscalzo J. Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res. 2006;99:1044-59.
24. Martinez-Vea A, Bardají A, Gutierrez C, Garcia C, Peralta C, Aguilera J, et al. Echocardiographic evaluation in patients with autosomal dominant polycystic kidney disease and end-stage renal disease. Am J Kidney Dis. 1999;34:264-72.
25. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001;286:421-6.
26. Gosling P. Microalbuminuria: a marker of systemic disease. Br J Hosp Med. 1995;54:285-90.
27. Martinez-Vea A, Gutierrez C, Bardají A, Pastor R, García C, Peralta C, et al. Microalbuminuria in normotensive patients with autosomal-dominant polycystic kidney disease. Scand J Urol Nephrol. 1998;32:356-9.
28. Bardají A, Martinez-Vea A, Gutierrez C, Ridao C, Richart C, Oliver JA. Left ventricular mass and diastolic function in normotensive young adults with autosomal dominant polycystic kidney disease. Am J Kidney Dis. 1998;32:970-5.
29. Valero FA, Martinez-Vea A, Bardají A, Gutierrez C, Garcia C, Richart C, et al. Ambulatory blood pressure and left ventricular mass in normotensive patients with autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 1999;10:1020-6.
30. Manjunath G, Tighiouart H, Ibrahim H, MacLeod B, Salem DN, Griffith JL, et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol. 2003;41:47-55.
31. Reis SE, Olson MB, Fried L, Reeser V, Mankad S, Pepine CJ, et al. Mild renal insufficiency is associated with angiographic coronary artery disease in women. Circulation. 2002;105:2826-9.
32. Colomer Asenjo I, De Castro Aritméndiz R, Serrano Rodríguez MI, Bonet Basiero A, Mercé Klein J, Valdovinos Perdices P, et al. El aclaramiento de creatinina como predictor de la extensión de enfermedad coronaria [resumen]. Rev Esp Cardiol. 2007;60 Supl 2:3.
33. Cases A. Otros factores de riesgo cardiovascular y renal. Hipertrofia del ventrículo izquierdo. Fibrilación auricular. Tabaquismo. Obesidad. Factores emergentes de riesgo cardiovascular: Homocisteína. Proteína C reactiva. Fibrinógeno. Nefrología. 2004;24 Supl 6:62-72.
34. Levin A, Singer J, Thompson CR, Ross H, Lewis M. Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. Am J Kidney Dis. 1996;27:347-54.
35. Martinez-Vea A, Valero FA, Bardaji A, Gutierrez C, Broch M, Garcia C, et al. Left ventricular hypertrophy in hypertensive patients with autosomal dominant polycystic kidney disease: influence of blood pressure and humoral and neurohormonal factors. Am J Nephrol. 2000;20:193-200.
36. Huting J, Kramer W, Schütterle G, Wizemann V. Analysis of left ventricular changes associated with chronic hemodialysis. Nephron. 1998;49:284-90.
37. Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. 1995;47:186-92.
38. Nitta K, Akiba T, Uchida K, Otsub S, Otsubo Y, Takei T, et al. Left ventricular hypertrophy is associated with arterial stiffness and vascular calcification. Hypertens Res. 2004;27:47-52.
39. Tyralla K, Amann K. Morphology of the heart and arteries in renal failure. Kidney Int Suppl 2003:63 Suppl 84:S80-3.
40. Stack AG, Saran R. Clinical correlates and mortality impact of left ventricular hypertrophy among new ESRD patients in the United States. Am J Kidney Dis. 2002;40:1202-10.
41. Cannella G, Paoletti E, Delfino R, Peloso G, Rolla D, Molinari S. Prolonged therapy with ACE inhibitors induces a regression of left ventricular hypertrophy of dialyzed uremic patients independently from hypotensive effects. Am J Kidney Dis. 1997;30:659-64.
42. Martinez-Vea A, Bardají A, García C, Ridao C, Richart C, Oliver JA. Long-term myocardial effects of correction of anemia with recombinant human erythropoietin in aged patients on hemodialysis. Am J Kidney Dis. 1992;19:353-7.
43. Manjunath G, Tighiouart H, Coresh J, Macleod B, Salem DN, Griffith JL, et al. Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int. 2003;63:1121-9.
44. Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol. 2006;17:2034-47.